Study of H5N1 Virus Infection in Mice
Author Information
Author(s): Evseenko Vasily A, Bukin Eugeny K, Zaykovskaya Anna V, Sharshov Kirill A, Ternovoi Vladimir A, Ignatyev George M, Shestopalov Alexander M
Primary Institution: State Research Center of Virology and Biotechnology 'Vector' of Rospotrebnadzor, Koltsovo, Russia
Hypothesis
Can the H5N1 HPAI virus strain A/duck/Tuva/01/06 be used to evaluate anti-influenza vaccines and therapeutics?
Conclusion
The study concluded that the A/duck/Tuva/01/06 virus can be used to evaluate anti-influenza vaccines and therapeutics.
Supporting Evidence
- The virus A/duck/Tuva/01/06 was characterized as highly pathogenic.
- Mean time to death of infected animals was 8.19 days.
- Acute delayed hemorrhagic syndrome was observed in the mice model.
- The virus showed sensitivity to adamantanes and neuraminidase inhibitors.
Takeaway
Researchers studied a virus that can make mice very sick to help create better vaccines for humans.
Methodology
The study involved infecting BALB/c mice with the H5N1 virus and observing the effects, including time to death and cytokine levels.
Potential Biases
Potential bias in the selection of viral strains and animal models.
Limitations
The study was conducted in a controlled environment, which may not fully replicate real-world conditions.
Participant Demographics
Inbred male BALB/c mice were used in the study.
Statistical Information
P-Value
1.4EID50
Confidence Interval
8.19 ± 0.18 days
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website